Siso, Ludger P.

HRN: 29-46-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/06/2026
08/13/2026
IV
4.5G
Q8
CAP MR WITH BRONCHIECTASIS AND LUNG FIBROSIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: